107 related articles for article (PubMed ID: 2986983)
41. [Autoantibodies to liver membrane in children with chronic active hepatitis (author's transl)].
Chauvel Y; Fernandez-Tello DS; Frommel D
Arch Fr Pediatr; 1980; 37 Suppl 2():V-VII. PubMed ID: 7447613
[TBL] [Abstract][Full Text] [Related]
42. Isolated rat hepatocytes as a tool for the determination of antibodies against human liver cell membrane.
Autuori F; Capucci E; Conti Devirgiliis L; Di Giacomo C; Dini L; Marinucci G
Biomed Pharmacother; 1983; 37(9-10):458-61. PubMed ID: 6372885
[TBL] [Abstract][Full Text] [Related]
43. Diagnosis of autoimmune chronic active hepatitis a simplified method for the detection of liver membrane autoantibodies (LMA).
Hopf U; Meyer zum Büschenfelde KH
Z Gastroenterol; 1978 Apr; 16(4):261-4. PubMed ID: 349905
[TBL] [Abstract][Full Text] [Related]
44. Hepatocellular localization of fetal antigens during induction of rat liver tumors by 3'-methyl-4-dimethylaminoazobenzene.
Cauchi MN; Halley JB; Irving MG; Williams JF
Cancer Res; 1974 Aug; 34(8):1808-12. PubMed ID: 4367121
[No Abstract] [Full Text] [Related]
45. Serum autoantibodies in hepatitis associated antigen (HAA) positive patients. A possible index of cell-mediated immunity to the associated-infective agent.
Dudley FJ; O'Shea MJ; Sherlock S
Clin Exp Immunol; 1973 Mar; 13(3):367-72. PubMed ID: 4349710
[TBL] [Abstract][Full Text] [Related]
46. Studies on plasma membranes. XVI. Tissue specific antigens in the liver cell surface.
Sheffield JB; Emmelot P
Exp Cell Res; 1972 Mar; 71(1):97-105. PubMed ID: 4112659
[No Abstract] [Full Text] [Related]
47. Humoral autoimmune response to nucleophosmin in the immunodiagnosis of hepatocellular carcinoma.
Liu M; Varela-Ramirez A; Li J; Dai L; Aguilera RJ; Zhang JY
Oncol Rep; 2015 May; 33(5):2245-52. PubMed ID: 25779011
[TBL] [Abstract][Full Text] [Related]
48. Antibodies to the surface of halothane-altered rabbit hepatocytes in patients with severe halothane-associated hepatitis.
Vergani D; Mieli-Vergani G; Alberti A; Neuberger J; Eddleston AL; Davis M; Williams R
N Engl J Med; 1980 Jul; 303(2):66-71. PubMed ID: 6991940
[TBL] [Abstract][Full Text] [Related]
49. Autoantibodies to the ribosomal P proteins react with a plasma membrane-related target on human cells.
Koren E; Reichlin MW; Koscec M; Fugate RD; Reichlin M
J Clin Invest; 1992 Apr; 89(4):1236-41. PubMed ID: 1313450
[TBL] [Abstract][Full Text] [Related]
50. Liver/kidney microsomal antibody type 1 targets CYP2D6 on hepatocyte plasma membrane.
Muratori L; Parola M; Ripalti A; Robino G; Muratori P; Bellomo G; Carini R; Lenzi M; Landini MP; Albano E; Bianchi FB
Gut; 2000 Apr; 46(4):553-61. PubMed ID: 10716687
[TBL] [Abstract][Full Text] [Related]
51. Exogenous hydrogen sulfide exerts proliferation/anti-apoptosis/angiogenesis/migration effects via amplifying the activation of NF-κB pathway in PLC/PRF/5 hepatoma cells.
Zhen Y; Pan W; Hu F; Wu H; Feng J; Zhang Y; Chen J
Int J Oncol; 2015 May; 46(5):2194-204. PubMed ID: 25738635
[TBL] [Abstract][Full Text] [Related]
52. Diversity of antinuclear antibody responses in hepatocellular carcinoma.
Covini G; von Mühlen CA; Pacchetti S; Colombo M; Chan EK; Tan EM
J Hepatol; 1997 Jun; 26(6):1255-65. PubMed ID: 9210612
[TBL] [Abstract][Full Text] [Related]
53. The detection of IgG anti-hepatocyte antibodies by ELISA in sera of patients with chronic active hepatitis: correlation with disease activity.
Wood LJ; Saar N; Searle J; Halliday JW; Powell LW
J Clin Lab Immunol; 1985 Aug; 17(4):167-71. PubMed ID: 4068030
[TBL] [Abstract][Full Text] [Related]
54. Hepatitis B surface antigen in hepatocytes at necropsy.
Ho JC; Wu PC; Gibson JB
Arch Pathol Lab Med; 1980 May; 104(5):255-7. PubMed ID: 6245627
[TBL] [Abstract][Full Text] [Related]
55. Occurrence and significance of antibody to liver-specific membrane lipoprotein by double-antibody immunoprecipitation method in sera of patients with acute and chronic liver diseases.
Kakumu S; Arakawa Y; Goji H; Kashio T; Yata K
Gastroenterology; 1979 Apr; 76(4):665-72. PubMed ID: 105959
[TBL] [Abstract][Full Text] [Related]
56. Suppression of HBsAg production in PLC/PRF/5 human hepatoma cell line by interferons.
Yamashita Y; Koike K; Takaoki M; Matsuda S
Microbiol Immunol; 1988; 32(11):1119-26. PubMed ID: 2464737
[TBL] [Abstract][Full Text] [Related]
57. Decreasing frequency, with time, of hepatitis B surface antigen positive liver biopsy in hepatitis, cirrhosis, and hepatocellular carcinoma.
Senba M; Nakamura T; Toda T; Matsumura H
Lancet; 1988 Mar; 1(8585):588-9. PubMed ID: 2894519
[No Abstract] [Full Text] [Related]
58. Screening of autoantibodies as potential biomarkers for hepatocellular carcinoma by using T7 phase display system.
Liu H; Zhang J; Wang S; Pang Z; Wang Z; Zhou W; Wu M
Cancer Epidemiol; 2012 Feb; 36(1):82-8. PubMed ID: 22018955
[TBL] [Abstract][Full Text] [Related]
59. Mouse monoclonal antibody directed against hepatitis B virus X protein synthesized in Escherichia coli: detection of reactive antigen in liver cell carcinoma and chronic hepatitis.
Zentgraf H; Herrmann G; Klein R; Schranz P; Loncarevic I; Herrmann D; Hübner K; Schröder CH
Oncology; 1990; 47(2):143-8. PubMed ID: 2156203
[TBL] [Abstract][Full Text] [Related]
60. Letter: Liver-membrane autoantibody in HBsAg-negative chronic active hepatitis.
N Engl J Med; 1976 Jul; 295(2):105-6. PubMed ID: 1272304
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
